Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

A home-school-doctor model to break the barriers for uptake of human papillomavirus vaccine

Authors: Albert Lee, Martin CS Wong, Tracy TN Chan, Paul KS Chan

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

A high coverage of human papillomavirus (HPV) vaccination is required to achieve a clinically significant reduction in disease burden. Countries implementing free-of-charge national vaccination program for adolescent girls are still challenged by the sub-optimal uptake rate. Voluntary on-site school-based mass vaccination programs have demonstrated high coverage. Here, we tested whether this could be an option for countries without a government-supported vaccination program as in Hong Kong.

Method

A Home-School-Doctor model was evolved based on extensive literature review of various health promotion models together with studies on HPV vaccination among adolescent girls. The outcome measure was uptake of vaccination. Factors associated with the outcome were measured by validated surveys in which 4,631 students from 24 school territory wide participated. Chi-square test was used to analyze association between the categorical variables and the outcome. Multivariate analysis was performed to identify independent variables associated with the outcome with vaccine group as case and non-vaccine group as control.

Results

In multivariate analysis, parental perception of usefulness of the Home-School-Doctor model had a very high odds ratio for uptake of HPV vaccination (OR 26.6, 95 % CI 16.4, 41.9). Paying a reasonable price was another independent factor associated with increased uptake (OR 1.71, 95 % CI 1.39, 2.1 for those with parents willing to pay US$125-250 for vaccination). For parents and adolescents who were not sure where to get vaccination, this model was significantly associated with improved uptake rate (OR 1.66, 95 % CI 1.23, 2.23). Concerns with side effects of vaccine (OR 0.70, 95 % CI 0.55, 0.88), allowing daughters to make their own decisions (OR 0.49, 95 % CI 0.38, 0.64) and not caring much about daughters’ social life (95 % CI 0.45, 0.92) were factors associated with a lower uptake.

Discussion

The findings of this study have added knowledge on how a school-based vaccination program would improve vaccine uptake rate even when the users need to pay. Our findings are consistent with other study that the most acceptable way to achieve high uptake of HPV vaccine is to offer voluntary school-based vaccination.

Conclusion

A model of care incorporating the efforts and expertise of academics and health professionals working closely with school can be applied to improve the uptake of vaccine among adolescent girls. Subsidized voluntary school-based vaccination scheme can be an option.
Literature
1.
Muñoz N, Kjaer SK, Sigurdsson K, Iversen QE, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on All HPV-associated genital disease in young women. J Natl Cancer Inst. 2010;102:325–39.CrossRefPubMed
2.
Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow S-N, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomized study in young women. Lancet. 2009;374:301–14.CrossRefPubMed
3.
Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis. 2005;191 Suppl 1:S97–106.CrossRefPubMed
4.
5.
Suárez E, Smith JS, Bosch FX, Nieminen P, Chen CJ, Torvinen S, et al. Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios. Vaccine. 2008;26 Suppl 5:29–45.CrossRef
6.
Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ. 2008;336:1056–8.CrossRefPubMedPubMedCentral
7.
Watson M, Shaw D, Molchanoff L, McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust NZ J Public Health. 2009;33:6844–51.CrossRef
8.
Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13–17 years-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:1018–23.
9.
Rouzier R, Giordanella J-P. Coverage and compliance of human papillomavirus vaccinies in Paris: Demonstration of low compliance with non-school-based approaches. J Adolesc Health. 2010;47:237–41.CrossRefPubMed
10.
Skinner S, Cooper Robbins S. Voluntary school-based human papillomavirus vaccination: an efficient and acceptable model for achieving high vaccine coverage in adolescents. J Adolesc Health. 2010;47:215–8.CrossRefPubMed
11.
12.
Middleman AB, Tung JS. Urban middle school parent perspectives: the vaccines they are willing to have their children receive using school-based immunization programs. J Adolesc Health. 2010;47:249–53.CrossRefPubMed
13.
Centers for Disease Control and Prevention. Vaccination coverage among adolescents aged 13–17 years- United States 2007. MMWR. 2008;57:1100–3.
14.
Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7(5):e1000270. Doi: 10371/journl.pmed.1000279.CrossRefPubMedPubMedCentral
15.
Gamble HL, Klosky JL, Parra GR, Randolph ME. Factors influencing familial decision-making regarding human papillomavirus vaccination. J PedPsy. 2010;35(7):704–15.
16.
Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health. 2010;7(3):279–86.CrossRefPubMedPubMedCentral
17.
Bandura A. Self-efficacy mechanism in psychobiologic functioning. In: Schwarzer R, editor. Self-efficacy: Thought control of action. Washington, DC: Hemisphere; 1992. p. 355–94.
18.
Brown DS, Reed Johnson F, Poulos C, Messonnier ML. Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirous. Vaccine. 2010;28:1702–8.CrossRefPubMed
19.
Garlanda S, Park SN, Ngan HYS, Frazer I, Tay EH, Chen CJ, et al. The need for public education on HPV and cervical cancer prevention in Asia: Opinions of experts at the AOGIN Conference. Vaccine. 2008;26(43):5435–40.CrossRef
20.
Lu C, Santosham M, APECI members. Survey of national immunization programs and vaccine coverage rates in Asia Pacfic coutries. Vaccine. 2012;30:2250–5.CrossRefPubMed
21.
Choi HCW, Leung GM, Woo PPS, Jit M, Wu JT. Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: A survey of mothers and adolescents. Vaccine. 2012;32:78–84.CrossRef
22.
23.
Li SL, Lau YL, Lam TP, Yip PSF, Fan SYS, Ip P. HPV vaccination in Hong Kong: Uptake and reasons for non-vaccination amongst Chinese adolescent girls. Vaccine. 2013;31:5785–8.CrossRefPubMed
24.
Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30:3546–56.CrossRefPubMed
25.
Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine. 2010;28:2070–5.CrossRefPubMed
26.
Cates JR, Shafer A, Carpentier FD, Reiter PL, Brewer NT, McRee AL, et al. How parents hear about the human papillomavirus vaccine: Implications for update. J Adolesc Health. 2010;47:305–8.CrossRefPubMedPubMedCentral
27.
28.
Rosenthal SL, Rupp R, Zimet GD, Mezaa HM, Lozaa ML, Short MB, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccination attitudes. J Adolesc Health. 2008;43(3):239–45.CrossRefPubMed
29.
Reiter PL, Brewer NT, Gottlieb SL, McReea A-L, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69:475–80.CrossRefPubMed
30.
Chow SN, Soon R, Park JS, Pancharoen C, Qiao YL, Basu P, et al. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine. 2010;28:3809–17.CrossRefPubMed
31.
Lee A, Chan PKS, Lau LCH, Chan TTN. How would Family Physicians facilitate the uptake of HPV vaccination: Focus group study on parents and single women in Hong Kong. Hong Kong Practitioner. 2011;33(3):107–14.
32.
Ajzen I. The Social Psychology of Decision-making. In: Kruglanski AW, Higgins ET, editors. Social Psychology: handbook of basic principles. 1st ed. New York: Academic; 1996. p. 297–328.
33.
Black LL, Zimet GD, Short MB, Sturm L, Rosenthal SL. Literature review of human papillomaviorus vaccine acceptability among women over 26 years. Vaccine. 2009;27:1668–73.CrossRefPubMed
34.
Van Keulen HM. Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross sectional study. BMC Public Health. 2013;13:111.CrossRefPubMedPubMedCentral
35.
Leask J, Chapman S, Hawe P. Burgess: What maintains parental support for vaccination when challenged byanti-vaccination messages? A qualitative study. Vaccine 2006; 24:7238–45.CrossRefPubMed
36.
Agius PA, Pitts MK, Smith AMA, Mitchell A. Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine. 2010;28(27):4416–22.CrossRefPubMed
37.
Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initation among adolescent girls in a high-risk geographic area. Sexually Transmitted Disease. 2011;38(3):197–204.CrossRef
38.
Barbin L, Roberts SA, Stretch R, Baxter D, Elton P, Kitchener H, et al. A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer. 2009;101(9):1502–4.CrossRef
39.
Udesky L. Push to mandate HPV vaccine triggers backlash in USA. Lancet. 2007;369:m979–80.CrossRef
40.
Harber G, Marlow RM, Zimet GD. The HPV vaccine mandate controversy. J PediatrAdolesc Gynecol. 2007;20:325–31.CrossRef
41.
Haley SJB, Yoshioka E, Ito Y, Konno R, Hayashi Y, Kishi R, et al. Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls. Vaccine. 2012;30:5740–47.CrossRef
42.
Tissot AM, Zimet GD, Rosenthal SL, Bernsteain DI, Wetzel C, Kahn JA. Effective Strategies for HPV Vaccine Delivery: The Views of Pediatricians. J Adol Health. 2007;41(2):119–25.CrossRef
43.
St Leger L, Kobe LJ, Lee A, McCall D, Young I. School Health: Achievements, Challenges and Priorities. In: McQueen DV, Jones CM, editors. Global Perspective on Health Promotion Effectiveness. 1st ed. New York: Springer; 2007. p. 107–24.CrossRef
44.
Lee A. Health Promoting Schools: Evidence for a holistic approach in promoting health and improvement of health literacy. Appl Health Econ Health Policy. 2009;7(1):11–7.CrossRefPubMed
45.
Garland SM, Skinner SR, Brotherton JML. Adolescent and young adult HPV vaccination in Australia: Achievements and challenges. Prev Med. 2011;53:S29–35.CrossRefPubMed
46.
Kyngas H, Rissanen M. Support as a crucial predictor of good compliance of adolescents with a chronic disease. J Clin Nurs. 2001;10(6):767–74.CrossRefPubMed
47.
Lee A, Tsang KK, Healthy Schools Research Support Group. Youth Risk Behaviour in a Chinese Population: A territory wide Youth Risk Behavioural Surveillance in Hong Kong. Public Health. 2004;118(2):88–95.CrossRefPubMed
48.
49.
Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, et al. Parental intention to have daughters receive the human papillomavirus vaccine. Can Med Association J. 2007;117:1506–12.CrossRef
50.
Clement CJ, Abdool-Karim Q, Chang ML, Nkpwane B, Esparza J. Breaking new ground—are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents? Vaccine. 2004;22(21–22):2822–26.CrossRef
51.
Doors M. Expert voices for change: Bridging the silos—towards healthy and sustainable settingsforthe21stcentury. Health Place. 2013;20:39–50.CrossRef
52.
Saultz JW, Lochner J. Interpersonal continuity of care and care outcomes: a critical review. Annals Fam Med. 2005;3:159–66.CrossRef
53.
Parchman ML, Burge SK. The Patient-Physician Relationship, Primary Care Attributes, and Preventive Services. Fam Med. 2003;36:22–7.
Metadata
Title
A home-school-doctor model to break the barriers for uptake of human papillomavirus vaccine
Authors
Albert Lee
Martin CS Wong
Tracy TN Chan
Paul KS Chan
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-2269-1

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Study protocol

Rationale, design and baseline characteristics of a randomized controlled trial of a web-based computer-tailored physical activity intervention for adults from Quebec City

Research article

Quality of life in persons living with HIV in Burkina Faso: a follow-up over 12 months

Research article

Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review

Study protocol

A web-based intervention for abused women: the New Zealand isafe randomised controlled trial protocol

Study protocol

Protocol for a randomised controlled trial of a web-based healthy relationship tool and safety decision aid for women experiencing domestic violence (I-DECIDE)

Research article

Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study